Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Identification of NS5B resistance-associated mutations in hepatitis C virus circulating in treatment-naïve Cameroonian patients
- Mounchili-Njifon A. , et al.
2. Hepatitis C virus infection in Iran: A review of current prevalence and preventive strategies from a developing country
- Tantuoyir M.M. , et al.
3. Negative Correlation of Interleukin-38 Serum Level with Alkaline Phosphatase and Persistent Hepatitis C Infection
- Rokhtabnak N. , et al.
4. An on-site community-based model for hepatitis C screening, diagnosis, and treatment among people who inject drugs in Kerman, Iran: The Rostam study
- Mirzazadeh A. , et al.
5. Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disorders
- Sharafi H. , et al.
6. First report on molecular docking analysis and drug resistance substitutions to approved HCV NS5A and NS5B inhibitors amongst Iranian patients
- Hasanshahi Z. , et al.
7. An intervention to increase hepatitis C virus diagnosis and treatment uptake among people in custody in Iran
- Hariri S. , et al.
8. Prevalence of Naturally Occurring Resistance Associated Substitutions in NS3/4AProtease Inhibitors in Iranian HCV/HIV Infected Patients
- Baesi K. , et al.
9. The efficacy and safety of sofosbuvir/daclatasvir fixed-dose combination in iranian hemodialysis patients with hepatitis C virus infection
- Ghanaat K. , et al.
10. Distribution of naturally -occurring NS5B resistance-associated substitutions in Egyptian patients with chronic Hepatitis C
- Ahmed H.R. , et al.
11. Hepatitis C rapid point-of-care testing and laboratory-based non-invasive assessment of liver fibrosis among drug abusers: An experience from Iran
- Hedayati-Moghaddam M.R. , et al.
12. Assessing the quality of clinical practice guidelines in the middle east and north africa (Mena) region: A systematic review
- Almazrou S.H. , et al.
13. Variations in IL-22, IL-27 and IL-35 serum levels in untreated and treated hepatitis C patients
- Taghinejad A. , et al.
14. Evaluating Drug Resistant Mutations to HCV NS3 Protease Inhibitors in Iranian Naïve Patients
- Hashempour T. , et al.
15. Patient-reported outcomes of sleep, mood and quality of life after treatment of chronic hepatitis C infection using direct-acting antiviral agents
- Karimi-Sari H. , et al.
17. The hepatitis C virus in Iran: Health policy, historical, ethical issues and future challenges
- Behzadifar M. , et al.
18. Community viral load and hepatitis C virus infection: Community viral load measures to aid public health treatment efforts and program evaluation
- Jordan A.E. , et al.
19. Real-life efficacy of generic sofosbuvir/ledipasvir for treatment of Iranian patients with chronic hepatitis C: A cohort study
- Sharafi H. , et al.
20. Signature of natural resistance in NS3 protease revealed by deep sequencing of HCV strains circulating in Iran
- Cuypers L. , et al.
21. Naturally occurring NS5A and NS5B resistant associated substitutions in HCV and HCV/HIV patients in iranian population
- Ramezani A. , et al.
22. Pooled Prevalence of NS5A Resistance-Associated Substitutions in Chronic HCV Genotype 3 Infection: A Study Based on Deposited Sequences in GenBank
- Sharafi H. , et al.
23. Aflatoxin B1 exposure and the risk of hepatocellular carcinoma in Iranian carriers of viral hepatitis B and C
- Habibi N. , et al.